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SUPPLEMENTAL TABLES 
Supplemental Table 1.  Genome location (hg19), barcode and DNA sequence information for 
all CEBPB binding sites and scrambled control sequences.  
 
Supplemental Table 2.  The number of total CEBPB binding sites across distinct categories of 
sites and the number, as well as percentage, of active binding events (driving activity above the 
95th percentile cutoff of scrambled control sequences) are given for HepG2 and K562 cells.  
 
Supplemental Table 3.  Genomic annotation analysis of CEBPB binding site CRE-seq activity.    
 
Supplemental Table 4.  Genomic annotation analysis of cell type-specific CEBPB binding site 
CRE-seq activity.    
 
 
SUPPLEMENTAL FIGURES 
Supplemental Figure 1.  CEBPB binding site analysis.   (A) Venn diagram of reproducible 
CEBPB binding events, found in two independent ChIP-seq replicate experiments in HepG2 
(shown in blue) and K562 (shown in red) cells.  The number of sites shared in both cell types is 
shown in gray.  (B) Bar plots of the percentage of CEBPB sites in HepG2 and K562 cells that 
harbor a canonical CEBPB binding motif is given in green, while sites devoid of a CEBPB motif 
are shown in red. 
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Supplemental Figure 2.  Read fraction comparisons of DNA and RNA.  (A) Comparisons of 
read count measurements for all identical barcodes across biological replicates in HepG2 cells.  
Data for DNA-derived (plasmid) barcodes are shown at the left while RNA-derived barcodes are 
given at the right. (B) Comparisons of read count measurements for all identical barcodes 
across biological replicates in K562 cells.  Data for DNA-derived (plasmid) barcodes are shown 
at the left while RNA-derived barcodes are given at the right.  
 
Supplemental Figure 3.  Read tag counts comparisons of DNA and RNA.  Pair-wise 
correlations (R2) of read tag counts for DNA and RNA is given across biological replicates and 
for both HepG2 and K562 cells.  In addition, correlations are given for read tag counts obtained 
directly from the plasmid pool (by sequencing the plasmid pool directly without transfection).  
Strong correlation is observed for biological replicates of RNA measurements within the same 
cell line.  DNA as well as plasmid pool measurements are strong across replicate experiments 
and across cell lines, suggesting that both cell lines were transfected with the same CRE-seq 
plasmid pool.  Strong correlations are shown in dark blue, lower correlations are given in lighter 
blue and low correlation is shown in red. 
 
Supplemental Figure 4. Analysis of luciferase activity in CRE-seq activity categories.  (A) 
A plot HepG2 luciferase activities in groups binned by HepG2 CRE-seq activities.  Binding sites 
were ranked on CRE-seq activity (x-axis) and grouped evenly (6 per group) into low activity 
sites (6 sites exhibiting the lowest HepG2 CRE-seq activity, labeled LOW), middle activity sites 
(labeled MID), and high activity sites (6 sites with the strongest HepG2 CRE-seq activity, 
labeled HIGH).  Group labels are shown on the x-axis and log2 transformed luciferase activities 
are shown on the y-axis.  Significant differences in activity are observed for both high and 
middle activity groups when compared to the activities of the low activity group (two-sided t-test; 
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HIGH versus LOW p < 3.5e-4, MID versus LOW p <0.02).  (B) A plot K562 luciferase activities 
in groups binned by K562 CRE-seq activities.  Binding sites were ranked on CRE-seq activity 
(x-axis) and grouped evenly (6 per group) into low activity sites (6 sites exhibiting the lowest 
K562 CRE-seq activity, labeled LOW), middle activity sites (labeled MID), and high activity sites 
(6 sites with the strongest K562 CRE-seq activity, labeled HIGH).  Group labels are shown on 
the x-axis and log2 transformed luciferase activities are shown on the y-axis.  Significant 
differences in activity are observed for the HIGH activity group when compared to the activities 
of the low activity group (two-sided t-test; HIGH versus LOW p <0.03).  For HepG2 cells, 6 out 
of 6 HIGH sites, 6 out of 6 MID sites and 0 out of 6 LOW sites fell above the 95% cutoff, while 
for K562 cells, 6 out of 6 HIGH sites, 4 out of 6 MID sites and 0 out of 6 LOW sites fell above 
the 95% cutoff. 
 
Supplemental Figure 5.  Shared CEBPB sites with and without RNAP2 co-occupancy.  (A) 
HepG2 CRE-seq activity for CEBPB sites shared between HepG2 and K562 cells is shown as 
box plots. The log2-transformed HepG2 CRE-seq activity (RNA/DNA barcode counts) is 
displayed on the y-axis.  Shared binding sites that are coincident with promoter-distal RNAP2 
are shown in dark blue and the scrambled control sequences for these RNAP2-associated 
binding sites are displayed in dark gray.  Shared binding sites devoid of promoter-distal RNAP2 
binding are displayed in light blue and the scrambled control sequences for these RNAP2-
devoid sites are shown in light gray.  The percentage of RNAP2-associated and RNAP2-devoid 
shared sites above the 95th percentile of associated scrambled control sites in HepG2 cells are 
displayed on the plot. (B) K562 CRE-seq activity for CEBPB sites shared between HepG2 and 
K562 cells is shown as box plots. The log2-transformed K562 CRE-seq activity (RNA/DNA 
barcode counts) is displayed on the y-axis.  Shared binding sites that are coincident with 
promoter-distal RNAP2 are shown in dark red and the scrambled control sequences for these 
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RNAP2-associated binding sites are displayed in dark gray.  Shared binding sites devoid of 
promoter-distal RNAP2 binding are displayed in light red and the scrambled control sequences 
for these RNAP2-devoid sites are shown in light gray.  The percentage of RNAP2-associated 
and RNAP2-devoid shared sites above the 95th percentile of associated scrambled control sites 
in K562 cells are displayed on the plot.  
 
Supplemental Figure 6.  RNAP2 ChIP-seq signal at active and inactive sites.  (A) Box plots 
display RNAP2 HepG2 ChIP-seq signal enrichments (y-axis) at active HepG2 CEBPB sites 
above 95th percentile of control sequences (labeled Active sites) and inactive HepG2 CEBPB 
sites with activity below 95th percentile of control sequences sites in HepG2 cells (labeled 
Inactive sites).  (B) Box plots display RNAP2 K562 ChIP-seq signal enrichments at active K562 
CEBPB sites above 95th percentile of control sequences (labeled Active sites) and inactive K562 
CEBPB sites with activity below 95th percentile of control sequences sites in K562 cells (labeled 
Inactive sites).  RNAP2 occupancy at CEBPB sites was assessed through normalized read 
counts (reads per million total sequenced reads) and is displayed on the y-axis.  Significantly 
higher signal (p= 3.211e-10 in HepG2 cells and p=4.059e-08 in K562 cells) was observed at 
active sites in both cell lines.  P-values are shown on each graph.  
 
Supplemental Figure 7.  eRNA GRO-seq signal at active and inactive sites.  (A) Box plots 
display eRNA GRO-seq signal enrichments (shown on the y-axis) at active K562 CEBPB sites 
above 95th percentile of control sequences (labeled Active sites) and inactive K562 CEBPB sites 
with activity below 95th percentile of control sequences sites in K562 cells (labeled Inactive 
sites).  Significantly higher signal (p= 3.211e-10) was observed at active sites.  The p-value is 
shown on the graph.  !
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